MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0001783
Market Cap
₹46.47 Cr
CRSTCHM · BSE
Share Price
₹142.10
-8.26% today
Revenue
₹29.61 Cr
FY 2025-26
EBITDA
₹3.19 Cr
Margin 10.8%
Net Profit
₹2.72 Cr
FY 2025-26
P/E (TTM)
17.0x
P/B 4.7x
ROE
27.4%
ROCE 37.8%
Authorised capital
₹4 Cr
Registered with MCA
About Crestchem Limited
Data last updated:
Crestchem Limited is a public limited company based in Indrad, Gujarat, India. It operates in the preventive health supplements segment of the healthcare sector. It was incorporated on 26 April 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24100GJ1991PLC015530. Its GSTIN is 24AAACC8722C1Z5 (Gujarat). It is a listed company as per MCA records. Its shares are listed on BSE: 526269.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Dipak Narendraprasad Patel (Managing Director) and Rinkal Maulik Jasani.
Its last annual general meeting (AGM) was held on 21 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Sr. No.550/1 Sub Plot No. 12 Village – Indrad Taluka – Kadi, Gujarat, India – 382715.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹29.61 Cr. For the same year it recorded a net profit of ₹2.72 Cr (net margin 9.2%) and EBITDA of ₹3.19 Cr (EBITDA margin 10.8%). The net worth stands at ₹9.89 Cr. Total assets are valued at ₹9.96 Cr.
The company is associated with 1 brand: Crestchem. Court records list 6 cases involving the company, including 1 filed by the company and 5 filed against it; 1 case is pending. The company has 2 deals on record (2 market trades); the latest was in September 2023. Its 5 peer companies in the Healthcare industry (Preventive Healthcare Supplements), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Biovencer Healthcare Private Limited with revenue of ₹28.51 Cr.
Crestchem Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0001783). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website crestchemlimited.in.
Company details
CIN L24100GJ1991PLC015530
Registration Number 015530
Incorporation Date 26 April 1991
ROC Ahmedabad
Listing Status Listed - Listed on BSE (526269)
Company Status Active
Date of Last AGM 21 August 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0001783
CIN history
Crestchem has one previous CIN (Corporate Identification Number): L24100GJ1991PTC015530. The current CIN is L24100GJ1991PLC015530, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24100GJ1991PLC015530 | Current |
| L24100GJ1991PTC015530 | Previous |
Key People
Dipak Narendraprasad Patel Managing Director Rinkal Maulik Jasani Director Priyankaben Manojkumar Patel Director Recognitions & Rankings of Crestchem
Contact details
Crestchem Limited's registered office is in Indrad, Gujarat. Its website is crestchemlimited.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSr. No.550/1 Sub Plot No. 12 Village – Indrad Taluka – Kadi, Gujarat, India – 382715
- IndustryHealthcare, Preventive Health Supplements
To see the full contact details of Crestchem Limited, buy the company report.
Comprehensive company report
Crestchem Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Crestchem operates one associated brand: Crestchem. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Triglycerides and skimmed milk powder are manufactured by Crestchem. | crestchemlimited.in |
Business activity
The main business activity of Crestchem is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Crestchem Limited, buy the company report.
Financials of Crestchem Limited
FY 2025-26 filings availableCrestchem Limited reported revenue of ₹29.61 Cr for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue
₹29.61 Cr
EBITDA
₹3.19 Cr
Profit After Tax
₹2.72 Cr
Net Worth
₹9.89 Cr
Total Assets
₹9.96 Cr
Total Debt
Nil
Financial summary ₹ Cr
| Metrics | FY 2025-26 |
|---|---|
| Income statement | |
| Revenue | 29.61 |
| EBITDA | 3.19 |
| EBITDA margin | +10.8% |
| Profit before tax | 3.77 |
| Net profit | 2.72 |
| Net profit margin | +9.2% |
| EPS (₹) | 9.05 |
| Balance sheet | |
| Total assets | 9.96 |
| Net worth | 9.89 |
| Total debt | 0.00 |
| Cash & bank | 0.41 |
| Net working capital | (0.62) |
| Cash flow | |
| Cash from operations | 3.59 |
| Cash from investing | (3.75) |
| Cash from financing | (0.17) |
| Particulars | Jun 2026 | Mar 2026 |
|---|---|---|
| Revenue | 9.26 | 10.23 |
| Other income | 0.20 | 0.20 |
| EBITDA | 1.14 | 1.40 |
| EBITDA margin | +12.3% | +13.7% |
| Depreciation | 0.01 | 0.02 |
| Interest | 0.01 | 0.01 |
| Profit before tax | 1.32 | 1.57 |
| Tax | 0.38 | 0.48 |
| Net profit | 0.94 | 1.09 |
| EPS (₹) | 3.14 | 3.67 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 29.61 | 25.08 | 21.26 | 16.73 | 7.95 | 7.64 | 6.20 |
| Revenue growth | +18.1% | +18.0% | +27.1% | +110.4% | +4.1% | +23.2% | - |
| EBITDA | 3.19 | 3.33 | 2.78 | 0.83 | 0.76 | 0.65 | 0.56 |
| EBITDA margin | +10.8% | +13.3% | +13.1% | +5.0% | +9.6% | +8.5% | +9.0% |
| Profit before tax | 3.77 | 3.67 | 2.98 | 0.95 | 0.79 | 0.66 | 0.57 |
| Net profit | 2.72 | 2.74 | 2.15 | 0.70 | 0.58 | 0.56 | 0.44 |
| Net profit margin | +9.2% | +10.9% | +10.1% | +4.2% | +7.3% | +7.3% | +7.1% |
| EPS (₹) | 9.05 | 9.09 | 7.15 | 2.31 | 1.89 | 1.91 | 1.48 |
| Balance sheet | |||||||
| Total assets | 9.94 | 7.55 | 4.93 | 2.77 | 2.33 | 2.16 | 0.93 |
| Net worth | 9.89 | 7.48 | 4.90 | 2.75 | 2.06 | 1.49 | 0.92 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.63 | 0.02 |
| Cash & bank | 0.41 | 0.73 | 0.15 | 0.87 | 0.01 | 0.97 | 0.64 |
| Net working capital | (0.72) | 1.31 | 0.09 | (0.80) | 0.22 | 1.87 | 0.72 |
| Cash flow | |||||||
| Cash from operations | 3.59 | 1.66 | 0.35 | 2.21 | 0.82 | 0.39 | 0.33 |
| Cash from investing | (3.75) | (0.99) | (1.07) | (1.34) | (0.83) | (0.39) | (0.35) |
| Cash from financing | (0.17) | (0.09) | (0.01) | (0.01) | (0.02) | (0.02) | 0.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.18 | 10.23 | 7.16 | 7.19 | 5.03 | 7.23 | 4.80 | 7.80 |
| Revenue growth (YoY) | +82.5% | +41.5% | +49.2% | -7.8% | -4.2% | - | - | - |
| Other income | 0.20 | 0.20 | 0.18 | 0.15 | 0.13 | 0.14 | 0.09 | 0.12 |
| Total expenses | 8.00 | 8.83 | 6.35 | 6.58 | 4.67 | 6.63 | 4.15 | 6.53 |
| EBITDA | 1.18 | 1.40 | 0.81 | 0.61 | 0.36 | 0.60 | 0.65 | 1.27 |
| EBITDA margin | +12.9% | +13.7% | +11.3% | +8.5% | +7.2% | +8.3% | +13.5% | +16.3% |
| Depreciation | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| Interest | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 1.36 | 1.57 | 0.97 | 0.74 | 0.47 | 0.72 | 0.73 | 1.38 |
| Tax | 0.38 | 0.48 | 0.25 | 0.19 | 0.12 | 0.11 | 0.20 | 0.39 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 28 Oct 2026
| Particulars | Jun 2026 | Mar 2026 |
|---|---|---|
| Revenue | 9.26 | 10.23 |
| Other income | 0.20 | 0.20 |
| EBITDA | 1.14 | 1.40 |
| EBITDA margin | +12.3% | +13.7% |
| Depreciation | 0.01 | 0.02 |
| Interest | 0.01 | 0.01 |
| Profit before tax | 1.32 | 1.57 |
| Tax | 0.38 | 0.48 |
| Net profit | 0.94 | 1.09 |
| EPS (₹) | 3.14 | 3.67 |
| Particulars | FY 2025-26 |
|---|---|
| Revenue | 29.61 |
| Other income | 0.66 |
| Total expenses | 26.42 |
| Employee cost | 1.19 |
| EBITDA | 3.19 |
| EBITDA margin | +10.8% |
| Depreciation | 0.07 |
| Interest | 0.01 |
| Profit before tax | 3.77 |
| Tax | 1.05 |
| Net profit | 2.72 |
| Net profit margin | +9.2% |
| EPS (₹) | 9.05 |
| Particulars | FY 2025-26 |
|---|---|
| Equity & liabilities | |
| Share capital | 3.00 |
| Reserves & surplus | 6.89 |
| Shareholders' funds (net worth) | 9.89 |
| Minority interest | 0.03 |
| Secured loans | 0.00 |
| Unsecured loans | 0.00 |
| Total debt | 0.00 |
| Total liabilities | 9.96 |
| Assets | |
| Gross block | 1.05 |
| Net block | 0.20 |
| Capital work in progress | 0.00 |
| Investments | 0.00 |
| Inventories | 0.00 |
| Sundry debtors | 3.61 |
| Cash & bank balances | 0.41 |
| Loans & advances | 1.64 |
| Total current assets | 5.66 |
| Total current liabilities | 6.28 |
| Net working capital | (0.62) |
| Total assets | 9.96 |
| Particulars | FY 2025-26 |
|---|---|
| Opening cash | 0.73 |
| Net cash from operating activities | 3.59 |
| Net cash from investing activities | (3.75) |
| Net cash from financing activities | (0.17) |
| Net change in cash | (0.33) |
| Closing cash | 0.41 |
| Particulars | FY 2025-26 |
|---|---|
| Growth | |
| PBT growth | +9997.0% |
| Profitability & leverage | |
| Net income margin | +9.2% |
| Return on capital employed | +37.8% |
| Return on net worth | +27.4% |
| Debt / equity | 0.00 |
| Long-term debt / equity | 0.00 |
| Interest cover | 0.32 |
| Efficiency & per share | |
| Fixed asset turnover | 28.20 |
| Inventory turnover | 0.00 |
| Debtors turnover | 8.20 |
| EPS (₹) | 9.05 |
| Dividend per share (₹) | 1.50 |
| Book value per share (₹) | 32.95 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.18 | 10.23 | 7.16 | 7.19 | 5.03 | 7.23 | 4.80 | 7.80 |
| Revenue growth (YoY) | +82.5% | +41.5% | +49.2% | -7.8% | -4.2% | - | - | - |
| Other income | 0.20 | 0.20 | 0.18 | 0.15 | 0.13 | 0.14 | 0.09 | 0.12 |
| Total expenses | 8.00 | 8.83 | 6.35 | 6.58 | 4.67 | 6.63 | 4.15 | 6.53 |
| EBITDA | 1.18 | 1.40 | 0.81 | 0.61 | 0.36 | 0.60 | 0.65 | 1.27 |
| EBITDA margin | +12.9% | +13.7% | +11.3% | +8.5% | +7.2% | +8.3% | +13.5% | +16.3% |
| Depreciation | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| Interest | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 1.36 | 1.57 | 0.97 | 0.74 | 0.47 | 0.72 | 0.73 | 1.38 |
| Tax | 0.38 | 0.48 | 0.25 | 0.19 | 0.12 | 0.11 | 0.20 | 0.39 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 29.61 | 25.08 | 21.26 | 16.73 | 7.95 | 7.64 | 6.20 |
| Revenue growth | +18.1% | +18.0% | +27.1% | +110.4% | +4.1% | +23.2% | - |
| Other income | 0.66 | 0.44 | 0.26 | 0.15 | 0.08 | 0.05 | 0.03 |
| Total expenses | 26.42 | 21.75 | 18.48 | 15.90 | 7.19 | 6.99 | 5.64 |
| Employee cost | 1.19 | 1.16 | 0.67 | 0.53 | 0.26 | 0.47 | 0.13 |
| EBITDA | 3.19 | 3.33 | 2.78 | 0.83 | 0.76 | 0.65 | 0.56 |
| EBITDA margin | +10.8% | +13.3% | +13.1% | +5.0% | +9.6% | +8.5% | +9.0% |
| Depreciation | 0.07 | 0.05 | 0.05 | 0.02 | 0.03 | 0.02 | 0.02 |
| Interest | 0.01 | 0.05 | 0.01 | 0.01 | 0.02 | 0.02 | 0.00 |
| Profit before tax | 3.77 | 3.67 | 2.98 | 0.95 | 0.79 | 0.66 | 0.57 |
| Tax | 1.05 | 0.93 | 0.83 | 0.25 | 0.21 | 0.10 | 0.13 |
| Net profit | 2.72 | 2.74 | 2.15 | 0.70 | 0.58 | 0.56 | 0.44 |
| Net profit margin | +9.2% | +10.9% | +10.1% | +4.2% | +7.3% | +7.3% | +7.1% |
| EPS (₹) | 9.05 | 9.09 | 7.15 | 2.31 | 1.89 | 1.91 | 1.48 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Reserves & surplus | 6.89 | 4.48 | 1.90 | (0.25) | (0.94) | (1.51) | (2.08) |
| Shareholders' funds (net worth) | 9.89 | 7.48 | 4.90 | 2.75 | 2.06 | 1.49 | 0.92 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.63 | 0.02 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.63 | 0.02 |
| Total liabilities | 9.94 | 7.55 | 4.93 | 2.77 | 2.33 | 2.16 | 0.93 |
| Assets | |||||||
| Gross block | 1.05 | 1.05 | 0.91 | 0.79 | 0.77 | 0.77 | 0.72 |
| Net block | 0.20 | 0.27 | 0.18 | 0.10 | 0.11 | 0.13 | 0.11 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Sundry debtors | 3.61 | 2.56 | 1.53 | 0.02 | 0.90 | 1.41 | 1.21 |
| Cash & bank balances | 0.41 | 0.73 | 0.15 | 0.87 | 0.01 | 0.97 | 0.64 |
| Loans & advances | 1.61 | 1.02 | 0.62 | 0.33 | 0.27 | 0.31 | 0.21 |
| Total current assets | 5.63 | 4.31 | 2.30 | 1.22 | 1.18 | 2.69 | 2.07 |
| Total current liabilities | 6.35 | 3.00 | 2.21 | 2.02 | 0.96 | 0.82 | 1.35 |
| Net working capital | (0.72) | 1.31 | 0.09 | (0.80) | 0.22 | 1.87 | 0.72 |
| Total assets | 9.94 | 7.55 | 4.93 | 2.77 | 2.33 | 2.16 | 0.93 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.73 | 0.15 | 0.87 | 0.01 | 0.03 | 0.05 | 0.07 |
| Net cash from operating activities | 3.59 | 1.66 | 0.35 | 2.21 | 0.82 | 0.39 | 0.33 |
| Net cash from investing activities | (3.75) | (0.99) | (1.07) | (1.34) | (0.83) | (0.39) | (0.35) |
| Net cash from financing activities | (0.17) | (0.09) | (0.01) | (0.01) | (0.02) | (0.02) | 0.00 |
| Net change in cash | (0.33) | 0.59 | (0.72) | 0.86 | (0.02) | (0.01) | (0.02) |
| Closing cash | 0.41 | 0.73 | 0.15 | 0.87 | 0.01 | 0.97 | 0.64 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +18.1% | +18.0% | +27.1% | +110.4% | +4.1% | +23.2% | - |
| EBITDA growth | -4.2% | +19.8% | +234.9% | +9.2% | +16.9% | +16.1% | - |
| PBT growth | +2.7% | +23.2% | +213.7% | +20.3% | +19.7% | +15.8% | +9998.0% |
| Net income growth | -0.7% | +27.4% | +207.1% | +20.7% | +3.6% | +27.3% | - |
| Revenue CAGR (3Y) | +21.0% | +46.7% | +40.7% | +39.2% | +330.0% | +434.6% | +253.8% |
| EBITDA CAGR (3Y) | +56.6% | +63.6% | +62.3% | +14.0% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +9.2% | +10.9% | +10.1% | +4.2% | +7.3% | +7.3% | +7.1% |
| Return on capital employed | +43.0% | +59.4% | +75.2% | +29.9% | +23.1% | +20.6% | +30.2% |
| Return on net worth | +31.2% | +44.1% | +54.4% | +23.0% | +19.0% | +19.0% | +25.4% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.05 | 0.25 | 0.27 | 0.22 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.32 | 1.52 | 0.37 | 1.23 | 2.74 | 3.17 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 28.20 | 25.59 | 25.01 | 21.45 | 10.32 | 10.26 | 8.67 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,528.00 | 620.00 |
| Debtors turnover | 9.60 | 12.26 | 27.43 | 36.37 | 6.88 | 5.83 | 9.61 |
| EPS (₹) | 9.05 | 9.09 | 7.15 | 2.31 | 1.89 | 1.91 | 1.48 |
| Dividend per share (₹) | 1.50 | 1.00 | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 32.95 | 24.92 | 16.33 | 9.18 | 6.87 | 4.97 | 3.06 |
To see the full year-wise statements and ratios of Crestchem Limited, buy the company report.
Board of directors of Crestchem Limited
Crestchem has 5 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dipak Narendraprasad Patel Also directs: Denis Chem Lab Limited, Oleo Biosciences Private Limited | Managing Director | 01 Feb 2008 | 18 Years 8 Months | Current |
| Rinkal Maulik Jasani Also directs: Shaival Reality Limited | Director | 28 May 2025 | 1 Years 5 Months | Current |
| Priyankaben Manojkumar Patel | Director | 04 Jul 2024 | 2 Years 3 Months | Current |
| Jignesh Ashvinkumar Shah Also directs: Silver Touch Technologies Limited | Director | 29 Dec 2023 | 2 Years 9 Months | Current |
| Nirmit Dipak Patel | Director | 17 Jul 2023 | 3 Years 3 Months | Current |
Peer comparison
Crestchem Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Supplements), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Crestchem Limitedthis company | ₹29.61 Cr (FY 2026) | ₹2.72 Cr | 9.2% | Indrad, Gujarat, India | ||
| Biovencer Healthcare Private Limited | ₹28.51 Cr (FY 2025) | -1.0% | Greater Noida, Uttar Pradesh, India | |||
| Molclone Labs Private Limited | ₹25.57 Cr (FY 2025) | 12.0% | Chennai, Tamil Nadu, India | |||
| Novel Nutrientss Private Limited | ₹25.26 Cr (FY 2024) | -1.0% | Bangalore, Karnataka, India | |||
| Healkraft Pharma (India) Private Limited | ₹25.01 Cr (FY 2025) | -1.0% | Chennai, Tamil Nadu, India | |||
| Zeon Biotech Private Limited | ₹24.1 Cr (FY 2024) | 19.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Crestchem Limited, buy the company report.
Auditor
Crestchem Limited is audited by SAMIR M SHAH & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAMIR M SHAH & ASSOCIATES | FY 2023 | 122377W |
Shareholding
Shareholding for the quarter ended Mar 2026: promoters hold 30.00%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.10% and retail and other public shareholders hold 69.90%.
Mar 2026
QUARTER
30.00% Promoters
0.10% DII (Domestic Institutional)
69.90% Retail & Others
Promoter holding - history
Now 30.00% · Mar 2026High 30.00% · Mar 2026Low 29.40% · Jun 2025
Shareholding trend - last 6 quarters
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 30.00% | 29.90% | 29.70% | 29.40% |
| Public | 70.00% | 70.10% | 70.30% | 70.60% |
Deals & funding
Crestchem Limited has 2 deals on record (2 market trades); the latest was in September 2023.
Total deals
2
Market trades
2
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2023 | Market trade | ₹13.8 Lakh | Seller: an individual |
| Nov 2020 | Market trade | ₹19.6 Lakh | Buyer: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Crestchem Limited has 6 court cases on record: 1 filed by Crestchem, 5 filed against it. 1 case is pending and 5 are disposed.
Total cases
6
Filed by the company
1
Filed against the company
5
Pending
1
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 5 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by The Registrar of Companies | Pending |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company by The Registrar of Companies | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Roc Bhavan,Registrar of Compaines | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against Regional Provident Fund Commissioner | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed against the company by Tirupati Trade Comm.Pvt.Ltd. Director - B.B.Agrawal and 1 other | Disposed |
To see the full case history of Crestchem Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Crestchem Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Crestchem has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACC8722C1Z5 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Crestchem Limited, buy the company report.
Recent activity
Crestchem Limited has 20 board changes on record since 1991: 13 appointments and 7 cessations. The latest: Nitinkumar Shantilal Shah was appointed as Company Secretary on 25 Aug 2025.
Filing
Crestchem Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
Appointed
Nitinkumar Shantilal Shah was appointed as Company Secretary.
AGM
Crestchem Limited last Annual general meeting of members was held on 21 Aug 2025 as per latest MCA records.
Appointed
Rinkal Maulik Jasani was appointed as Director.
Ceased
Binaben Parasbhai Patel ceased to be Director.
Ceased
Manojkumar Babubhai Patel ceased to be Director.
Appointed
Priyankaben Manojkumar Patel was appointed as Director.
Ceased
Rajesh Ishwarlal Mody ceased to be Director.
Appointed
Jignesh Ashvinkumar Shah was appointed as Director.
Appointed
Nirmit Dipak Patel was appointed as Director.
Appointed
Manojkumar Babubhai Patel was appointed as Director.
Ceased
Neil Darshan Dalal ceased to be Whole-Time Director.
11 earlier events are in the company report.
Frequently asked questions
Crestchem is an active public limited company based in Indrad, Gujarat, India. The company works in preventive health supplements, within the healthcare industry. It was incorporated on 26 April 1991 (35+ years old) and is registered under CIN L24100GJ1991PLC015530. Listed on BSE: 526269.
Crestchem reported revenue of ₹29.61 Cr for FY 2025-26 based on consolidated financials.
Crestchem has 5 current directors:
- Dipak Narendraprasad Patel - Managing Director
- Rinkal Maulik Jasani - Director
- Priyankaben Manojkumar Patel - Director
- Jignesh Ashvinkumar Shah - Director
- Nirmit Dipak Patel - Director
The latest financial statements of Crestchem on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 21 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Crestchem is 24AAACC8722C1Z5, registered in Gujarat.
The CIN (Corporate Identification Number) of Crestchem is L24100GJ1991PLC015530. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Crestchem is a listed company as per MCA records. Its shares are listed on BSE (code: 526269).
Crestchem has 6 court cases on record: 1 filed by the company and 5 filed against it. 1 is pending. Most are in the district courts.
Crestchem was incorporated on 26 April 1991, making it 35+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Crestchem has 2 deals on record (2 market trades); the latest was in September 2023.
The peers of Crestchem by revenue are Biovencer Healthcare Private Limited, Molclone Labs Private Limited, Novel Nutrientss Private Limited, Healkraft Pharma (India) Private Limited, Zeon Biotech Private Limited, all in the Healthcare industry (Preventive Healthcare Supplements), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).